Seattle, WA, United States of America

Debra G Gilbertson

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 262(Granted Patents)


Location History:

  • Seattle, WA (US) (2002 - 2014)
  • Lake Forest Park, WA (US) (2011 - 2017)

Company Filing History:


Years Active: 2002-2017

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Debra G. Gilbertson

Introduction

Debra G. Gilbertson, based in Seattle, WA, is a notable inventor with an impressive portfolio of 26 patents. Her work primarily focuses on advancements in the medical field, particularly in the treatment of neovascular disorders. Her innovative contributions have produced significant advancements in biotechnology, enhancing the understanding of receptor antagonists.

Latest Patents

One of her latest patents includes compositions and methods for inhibiting PDGF receptor β (PDGFRβ) and VEGF-A. This patent discloses antagonists, including neutralizing anti-PDGFRβ and anti-VEGF-A antibodies, alongside bispecific antibodies that can bind and neutralize both PDGFRβ and VEGF-A. These antibodies play a crucial role in the development of methods for treating neovascular disorders, such as cancer or ocular conditions associated with abnormal blood vessel growth.

Career Highlights

Debra has made remarkable strides in her career, working diligently at Zymogenetics, Inc. Her expertise in the field of biotechnology positions her as a leader in her domain, where her research and developments have the potential to revolutionize treatment methods for various medical conditions.

Collaborations

In her professional journey, Debra has collaborated with other esteemed innovators, including Charles E. Hart and Paul O. Sheppard. These partnerships have fostered an environment of innovation and knowledge sharing, further advancing their collective work in the realm of biotechnology and patentable inventions.

Conclusion

Debra G. Gilbertson's innovative contributions and dedication to her field have established her as a prominent figure in medical biotechnology. Her patents are a testament to her commitment to enhancing healthcare and providing new solutions for challenging medical conditions. Through her work at Zymogenetics, Inc., she continues to pave the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…